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Toward a Better Understanding of...

Identifying the Mechanisms in which
Zika Virus Crosses the Placenta and Induces
Fetal Infection
Meghal Sheth
Mentor: Indira Mysorekar
Zika virus (ZIKV) is a mosquito borne flavivirus that was first discovered in Uganda in
1947. Between 2007 and 2016, ZIKV has spread to the Americas and ZIKV has been
discovered to have a devastatingly profound neurological impact on adults, causing
Guillain Barré Syndrome. ZIKV in pregnant women can also induce congenital
complications like microcephaly in fetuses. 29% of fetuses in ZIKV infected mothers
have shown developmental abnormalities, and no vaccines or therapies have been
developed to combat ZIKV infection.
My research sought to understand how ZIKV specifically crosses the placenta and
induces infection. The inhibition of furin (FI), a proprotein convertase that has been
found to activate viruses like Chikungunya (CHIKV), was assessed due to its ability to
decrease the spread of ZIKV. An antimalarial drug, Hydroxychloroquine (HCQ), was
also assessed to see if there are therapeutic effects on infected placental trophoblast cells.
JEG-3 choriocarcinoma trophoblast cultures were infected with ZIKV and were then
co-treated with FI and HCQ. The viral burden was then measured via qRT-PCR. The
trophoblast cultures co-treated with the furin inhibitor had no statistically significant
decrease in viral burden compared to the ZIKV only treatment, however the HCQ cotreatment did have a significant decrease in viral burden. My findings show that ZIKV
infection does not appear to use the furin convertase to induce infection in placental
cells. However, HCQ treatment, which blocks autophagy processing required by ZIKV,
is effective in limiting infection.
The next step is to better understand the mechanism by which HCQ modulates
ZIKV infection and move closer to employing it as a therapeutic avenue to prevent the
damaging effects of ZIKV on fetuses.
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